ResearcherUniversity of North Carolina at Chapel HillActive in the last 2 years
Jiajie Zhang
Matched on ORCID iD 0000-0002-3510-4040; OpenAlex author ID A5100626088. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 4
- Ionizable cationic lipid nanoparticles loaded with miRNA-125b/BLZ945 for pancreatic cancer treatment. Co-author DOI 10.1002/bab.2701↗
- Role of microenvironmental periostin in pancreatic cancer progression. Co-author DOI 10.18632/oncotarget.11533↗
- Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. Co-author DOI 10.1007/s13277-016-5321-6↗
- Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. Co-author DOI 10.18632/oncotarget.9512↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Deliang Fu · 1 shared paper, 2025 · strength 0.30
- Lingxi Xing · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Lianfang Du · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Feng Gao · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Peng Qin · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Lizhou Lin · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Fan Li · 3 shared papers, 2016–2017 · strength 0.17
- Paper Role of microenvironmental periostin in pancreatic cancer progression. DOI 10.18632/oncotarget.11533↗
- Paper Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer. DOI 10.1007/s13277-016-5321-6↗
- Paper Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling. DOI 10.18632/oncotarget.9512↗
- Yang Liu · 1 shared paper, 2017 · strength 0.06
- Yang Liu · 1 shared paper, 2016 · strength 0.05
- Liu Yang · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.